Incyte (INCY) Net Margin (2010 - 2026)

Incyte (INCY) posted Net Margin of 23.83% for Q1 2026, up 20.0% on a QoQ basis from 19.86% in Q4 2025, and up 881.0% year-over-year from 2.43% in Q1 2025.

Incyte (INCY) Net Margin (2010 - 2026) Analysis & Trends

Incyte's Net Margin history runs 17 years deep, the most recent figure standing at 23.83% for Q1 2026.

  • Quarterly Net Margin rose 881.0% year-over-year to 23.83% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26.71% (up 2623.0% YoY) and the FY2025 annual result came in at 25.03%, up 2426.0% from the prior year.
  • Net Margin was 23.83% for Q1 2026 at Incyte, up from 19.86% in the prior quarter.
  • Across five years, Net Margin topped out at 33.32% in Q2 2025 and bottomed at 42.6% in Q2 2024.
  • A 5-year average of 13.43% and a median of 17.71% in 2022 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2024 — Net Margin tumbled 6392 bps — and 2025, when it soared 7591 bps.
  • Incyte's Net Margin stood at 3.07% in 2022, then jumped by 546 bps to 19.84% in 2023, then decreased by 14 bps to 17.07% in 2024, then advanced by 16 bps to 19.86% in 2025, then gained by 20 bps to 23.83% in 2026.
  • Business Quant data shows INCY's Net Margin at 23.83% in Q1 2026, 19.86% in Q4 2025, and 31.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 23.83%

Historic Data

Download Data
DateValue
Mar 31, 2026 23.83%
Dec 31, 2025 19.86%
Sep 30, 2025 31.05%
Jun 30, 2025 33.32%
Mar 31, 2025 15.03%
Dec 31, 2024 17.07%
Sep 30, 2024 9.36%
Jun 30, 2024 -42.60%
Mar 31, 2024 19.25%
Dec 31, 2023 19.84%
Sep 30, 2023 18.64%
Jun 30, 2023 21.32%
Mar 31, 2023 2.68%
Dec 31, 2022 3.07%
Sep 30, 2022 13.70%
Jun 30, 2022 17.71%
Mar 31, 2022 5.18%
Dec 31, 2021 65.35%
Sep 30, 2021 22.35%
Jun 30, 2021 21.18%